7 | Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
02/2015
-
02/2005 |
4 | edotreotide lutetium LU-177IBA
07/2015
-
01/2011 |
4 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2013
-
11/2007 |
3 | Edotreotide (SMT 487)IBA
03/2017
-
01/2011 |
3 | Radioisotopes (Radionuclides)IBA
01/2017
-
01/2011 |
3 | Somatostatin Receptors (Somatostatin Receptor)IBA
10/2016
-
01/2013 |
3 | AcidsIBA
04/2012
-
11/2007 |
3 | yttrium(III)- 1,4,7,10- tetraazacyclotetradecane- N,N',N'',N'''- tetraacetic acidIBA
04/2012
-
11/2007 |
2 | Peptide Receptors (Peptide Receptor)IBA
01/2017
-
01/2011 |
2 | DOTA-Tyr(3)- 90Y-octreotideIBA
01/2017
-
02/2015 |
2 | Octreotide (Sandostatin)FDA LinkGeneric
04/2012
-
06/2011 |
2 | Substance PIBA
10/2010
-
09/2007 |
1 | Natriuretic PeptidesIBA
10/2017 |
1 | Brain Natriuretic Peptide (Natrecor)FDA Link
10/2017 |
1 | somatostatin receptor 2IBA
03/2017 |
1 | DOTA(0)-Tyr(3)- 177Lu-octreotideIBA
02/2015 |
1 | omega-Chloroacetophenone (Mace)IBA
10/2014 |
1 | Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
02/2012 |
1 | Calcitonin (Calcitonin, Eel)FDA LinkGeneric
01/2010 |
1 | ProcalcitoninIBA
01/2010 |
1 | AntibodiesIBA
09/2009 |
1 | LigandsIBA
09/2007 |
1 | Antithyroid Agents (Antithyroid Drugs)IBA
03/2007 |
1 | Iodine-131IBA
10/2006 |
1 | CarbimazoleIBA
06/2006 |
1 | isopentaneIBA
06/2006 |
1 | RNA (Ribonucleic Acid)IBA
06/2006 |
1 | IfosfamideFDA LinkGeneric
02/2005 |
1 | Etoposide (VP 16)FDA LinkGeneric
02/2005 |
1 | Hydrochlorothiazide (Esidrix)FDA LinkGeneric
03/2003 |